The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global NHS-Activated MagBeads Market Research Report 2024

Global NHS-Activated MagBeads Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1765046

No of Pages : 90

Synopsis
NHS-Activated MagBeads are superparasitic nano-magnetic bead microspheres containing NHS (succinimide) functional groups, which can be coupled with primary amines on nucleic acids, proteins, antibodies or other molecules to form stable amide bonds. The coupled magnetic beads can be separated from the solution by magnetic field adsorption, and can be directly used in downstream enzyme reactions or immunopurification and separation of macromolecules.

Global NHS-Activated MagBeads market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NHS-Activated MagBeads market research.

Key manufacturers engaged in the NHS-Activated MagBeads industry include Thermo Fisher Scientific, BEAVER, AvanBio, Bioclone, RayBiotech, Cube Biotech, Cytiva, CD Bioparticles and Cultek, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of NHS-Activated MagBeads were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole NHS-Activated MagBeads market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global NHS-Activated MagBeads market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Thermo Fisher Scientific
  • BEAVER
  • AvanBio
  • Bioclone
  • RayBiotech
  • Cube Biotech
  • Cytiva
  • CD Bioparticles
  • Cultek
  • Beijing Baiao Leibo Technology
  • Yeasen Biotechnology
  • Xi'an Qiyue Biotechnology
  • Nanjing Dongna Biotechnology
  • Shanghai Acmec Biochemical

Segment by Type

  • Millimeter Level
  • Nanoscale Level

Segment by Application

  • Protein Purification
  • Immunoassay
  • Cell Sorting
  • Specific Nucleic Acid Isolation
  • Biological Sensor
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The NHS-Activated MagBeads report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 NHS-Activated MagBeads Market Overview
1.1 Product Overview and Scope of NHS-Activated MagBeads
1.2 NHS-Activated MagBeads Segment by Type
1.2.1 Global NHS-Activated MagBeads Market Value Comparison by Type (2023-2029)
1.2.2 Millimeter Level
1.2.3 Nanoscale Level
1.3 NHS-Activated MagBeads Segment by Application
1.3.1 Global NHS-Activated MagBeads Market Value by Application: (2023-2029)
1.3.2 Protein Purification
1.3.3 Immunoassay
1.3.4 Cell Sorting
1.3.5 Specific Nucleic Acid Isolation
1.3.6 Biological Sensor
1.3.7 Others
1.4 Global NHS-Activated MagBeads Market Size Estimates and Forecasts
1.4.1 Global NHS-Activated MagBeads Revenue 2018-2029
1.4.2 Global NHS-Activated MagBeads Sales 2018-2029
1.4.3 Global NHS-Activated MagBeads Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NHS-Activated MagBeads Market Competition by Manufacturers
2.1 Global NHS-Activated MagBeads Sales Market Share by Manufacturers (2018-2023)
2.2 Global NHS-Activated MagBeads Revenue Market Share by Manufacturers (2018-2023)
2.3 Global NHS-Activated MagBeads Average Price by Manufacturers (2018-2023)
2.4 Global NHS-Activated MagBeads Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of NHS-Activated MagBeads, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NHS-Activated MagBeads, Product Type & Application
2.7 NHS-Activated MagBeads Market Competitive Situation and Trends
2.7.1 NHS-Activated MagBeads Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NHS-Activated MagBeads Players Market Share by Revenue
2.7.3 Global NHS-Activated MagBeads Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NHS-Activated MagBeads Retrospective Market Scenario by Region
3.1 Global NHS-Activated MagBeads Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global NHS-Activated MagBeads Global NHS-Activated MagBeads Sales by Region: 2018-2029
3.2.1 Global NHS-Activated MagBeads Sales by Region: 2018-2023
3.2.2 Global NHS-Activated MagBeads Sales by Region: 2024-2029
3.3 Global NHS-Activated MagBeads Global NHS-Activated MagBeads Revenue by Region: 2018-2029
3.3.1 Global NHS-Activated MagBeads Revenue by Region: 2018-2023
3.3.2 Global NHS-Activated MagBeads Revenue by Region: 2024-2029
3.4 North America NHS-Activated MagBeads Market Facts & Figures by Country
3.4.1 North America NHS-Activated MagBeads Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America NHS-Activated MagBeads Sales by Country (2018-2029)
3.4.3 North America NHS-Activated MagBeads Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe NHS-Activated MagBeads Market Facts & Figures by Country
3.5.1 Europe NHS-Activated MagBeads Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe NHS-Activated MagBeads Sales by Country (2018-2029)
3.5.3 Europe NHS-Activated MagBeads Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NHS-Activated MagBeads Market Facts & Figures by Country
3.6.1 Asia Pacific NHS-Activated MagBeads Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific NHS-Activated MagBeads Sales by Country (2018-2029)
3.6.3 Asia Pacific NHS-Activated MagBeads Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NHS-Activated MagBeads Market Facts & Figures by Country
3.7.1 Latin America NHS-Activated MagBeads Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America NHS-Activated MagBeads Sales by Country (2018-2029)
3.7.3 Latin America NHS-Activated MagBeads Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa NHS-Activated MagBeads Market Facts & Figures by Country
3.8.1 Middle East and Africa NHS-Activated MagBeads Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa NHS-Activated MagBeads Sales by Country (2018-2029)
3.8.3 Middle East and Africa NHS-Activated MagBeads Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NHS-Activated MagBeads Sales by Type (2018-2029)
4.1.1 Global NHS-Activated MagBeads Sales by Type (2018-2023)
4.1.2 Global NHS-Activated MagBeads Sales by Type (2024-2029)
4.1.3 Global NHS-Activated MagBeads Sales Market Share by Type (2018-2029)
4.2 Global NHS-Activated MagBeads Revenue by Type (2018-2029)
4.2.1 Global NHS-Activated MagBeads Revenue by Type (2018-2023)
4.2.2 Global NHS-Activated MagBeads Revenue by Type (2024-2029)
4.2.3 Global NHS-Activated MagBeads Revenue Market Share by Type (2018-2029)
4.3 Global NHS-Activated MagBeads Price by Type (2018-2029)
5 Segment by Application
5.1 Global NHS-Activated MagBeads Sales by Application (2018-2029)
5.1.1 Global NHS-Activated MagBeads Sales by Application (2018-2023)
5.1.2 Global NHS-Activated MagBeads Sales by Application (2024-2029)
5.1.3 Global NHS-Activated MagBeads Sales Market Share by Application (2018-2029)
5.2 Global NHS-Activated MagBeads Revenue by Application (2018-2029)
5.2.1 Global NHS-Activated MagBeads Revenue by Application (2018-2023)
5.2.2 Global NHS-Activated MagBeads Revenue by Application (2024-2029)
5.2.3 Global NHS-Activated MagBeads Revenue Market Share by Application (2018-2029)
5.3 Global NHS-Activated MagBeads Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific NHS-Activated MagBeads Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 BEAVER
6.2.1 BEAVER Corporation Information
6.2.2 BEAVER Description and Business Overview
6.2.3 BEAVER NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BEAVER NHS-Activated MagBeads Product Portfolio
6.2.5 BEAVER Recent Developments/Updates
6.3 AvanBio
6.3.1 AvanBio Corporation Information
6.3.2 AvanBio Description and Business Overview
6.3.3 AvanBio NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AvanBio NHS-Activated MagBeads Product Portfolio
6.3.5 AvanBio Recent Developments/Updates
6.4 Bioclone
6.4.1 Bioclone Corporation Information
6.4.2 Bioclone Description and Business Overview
6.4.3 Bioclone NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bioclone NHS-Activated MagBeads Product Portfolio
6.4.5 Bioclone Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Corporation Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.5.4 RayBiotech NHS-Activated MagBeads Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 Cube Biotech
6.6.1 Cube Biotech Corporation Information
6.6.2 Cube Biotech Description and Business Overview
6.6.3 Cube Biotech NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cube Biotech NHS-Activated MagBeads Product Portfolio
6.6.5 Cube Biotech Recent Developments/Updates
6.7 Cytiva
6.6.1 Cytiva Corporation Information
6.6.2 Cytiva Description and Business Overview
6.6.3 Cytiva NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cytiva NHS-Activated MagBeads Product Portfolio
6.7.5 Cytiva Recent Developments/Updates
6.8 CD Bioparticles
6.8.1 CD Bioparticles Corporation Information
6.8.2 CD Bioparticles Description and Business Overview
6.8.3 CD Bioparticles NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CD Bioparticles NHS-Activated MagBeads Product Portfolio
6.8.5 CD Bioparticles Recent Developments/Updates
6.9 Cultek
6.9.1 Cultek Corporation Information
6.9.2 Cultek Description and Business Overview
6.9.3 Cultek NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cultek NHS-Activated MagBeads Product Portfolio
6.9.5 Cultek Recent Developments/Updates
6.10 Beijing Baiao Leibo Technology
6.10.1 Beijing Baiao Leibo Technology Corporation Information
6.10.2 Beijing Baiao Leibo Technology Description and Business Overview
6.10.3 Beijing Baiao Leibo Technology NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Beijing Baiao Leibo Technology NHS-Activated MagBeads Product Portfolio
6.10.5 Beijing Baiao Leibo Technology Recent Developments/Updates
6.11 Yeasen Biotechnology
6.11.1 Yeasen Biotechnology Corporation Information
6.11.2 Yeasen Biotechnology NHS-Activated MagBeads Description and Business Overview
6.11.3 Yeasen Biotechnology NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yeasen Biotechnology NHS-Activated MagBeads Product Portfolio
6.11.5 Yeasen Biotechnology Recent Developments/Updates
6.12 Xi'an Qiyue Biotechnology
6.12.1 Xi'an Qiyue Biotechnology Corporation Information
6.12.2 Xi'an Qiyue Biotechnology NHS-Activated MagBeads Description and Business Overview
6.12.3 Xi'an Qiyue Biotechnology NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Xi'an Qiyue Biotechnology NHS-Activated MagBeads Product Portfolio
6.12.5 Xi'an Qiyue Biotechnology Recent Developments/Updates
6.13 Nanjing Dongna Biotechnology
6.13.1 Nanjing Dongna Biotechnology Corporation Information
6.13.2 Nanjing Dongna Biotechnology NHS-Activated MagBeads Description and Business Overview
6.13.3 Nanjing Dongna Biotechnology NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nanjing Dongna Biotechnology NHS-Activated MagBeads Product Portfolio
6.13.5 Nanjing Dongna Biotechnology Recent Developments/Updates
6.14 Shanghai Acmec Biochemical
6.14.1 Shanghai Acmec Biochemical Corporation Information
6.14.2 Shanghai Acmec Biochemical NHS-Activated MagBeads Description and Business Overview
6.14.3 Shanghai Acmec Biochemical NHS-Activated MagBeads Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Shanghai Acmec Biochemical NHS-Activated MagBeads Product Portfolio
6.14.5 Shanghai Acmec Biochemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NHS-Activated MagBeads Industry Chain Analysis
7.2 NHS-Activated MagBeads Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NHS-Activated MagBeads Production Mode & Process
7.4 NHS-Activated MagBeads Sales and Marketing
7.4.1 NHS-Activated MagBeads Sales Channels
7.4.2 NHS-Activated MagBeads Distributors
7.5 NHS-Activated MagBeads Customers
8 NHS-Activated MagBeads Market Dynamics
8.1 NHS-Activated MagBeads Industry Trends
8.2 NHS-Activated MagBeads Market Drivers
8.3 NHS-Activated MagBeads Market Challenges
8.4 NHS-Activated MagBeads Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’